Coherus Biosciences | CHRS - EPS Earnings Per Share


Coherus Biosciences reported $-0.43 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Acadia Pharmaceuticals USD 0.18 0.16 Jun/2026
Akebia Therapeutics USD -0.04 0.04 Dec/2025
ALKERMES USD 0 0.4 Jun/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
Amarin USD 0.14 0.06 Dec/2025
Amgen USD 6.29 1.14 Jun/2026
Baxter International USD 0.58 0.02 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Coherus Biosciences USD -0.43 0.06 Dec/2025
Eli Lilly USD 7.48 0.9 Sep/2026
Fujifilm JPY 31.26 37.91 Jun/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
Ironwood Pharmaceuticals USD 0.31 0.07 Jun/2026
Merck USD 2.49 2.62 Sep/2026
Myriad Genetics USD -0.25 0.16 Jun/2026
Pacira USD 0.73 0.13 Jun/2026
Perrigo USD 0.5 0.07 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
Teva Pharmaceutical Industries USD 0.06 1.51 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026
Xencor USD -0.29 1.42 Jun/2026
Zoetis USD 1.87 0.34 Jun/2026